# The Synthetic Cannabinoid ADB-FUBINACA Disrupts Mitochondrial Morphology and Dynamics during Neuronal Differentiation of NG108-15 Cells

**Authors:** Rui Filipe Malheiro, Ana Catarina Costa, Catarina Pereira-Teixeira, Helena Carmo, Félix Carvalho, João Pedro Silva

PMC · DOI: 10.1007/s12035-026-05699-x · 2026-01-21

## TL;DR

This study shows that the synthetic cannabinoid ADB-FUBINACA disrupts mitochondrial structure and movement in developing neurons, which could affect long-term neurite maintenance.

## Contribution

The study reveals novel effects of ADB-FUBINACA on mitochondrial dynamics during neuronal differentiation at biologically relevant concentrations.

## Key findings

- ADB-FUBINACA reduced mitochondrial area and perimeter while increasing circularity and decreasing network branching.
- The drug decreased fusion markers and increased fission markers, leading to mitochondrial fragmentation.
- Mitochondrial motility in neurites was reduced, with more stationary mitochondria accumulating.

## Abstract

Mitochondria are essential drivers of neuronal growth, differentiation, and overall brain development. Synthetic cannabinoids (SCs) have been shown to enhance neurite outgrowth in NG108-15 neuroblastoma x glioma cells through CB1 receptor activation, while disrupting mitochondrial function. Here, we demonstrated first-hand the impact of biologically-relevant concentrations (< 1μM) of ADB-FUBINACA (an SC commonly identified in drug seizures) on mitochondrial morphology and dynamics (i.e., fusion, fission and mobility) during the neurodifferentiation of NG108-15 cells. Our findings revealed that, during NG108-15 neurodifferentiation, ADB-FUBINACA reduced the mean mitochondrial area and perimeter by around 10%, while increasing mitochondrial circularity, and decreasing network branching and interconnectivity. Specifically, branch length per mitochondrion and branch junctions declined by 17 and 25% in the neurons’ soma at the end of NG108-15 differentiation (after 72 h). Moreover, 1 nM and 1 µM ADB-FUBINACA markedly decreased the levels of mitochondrial fusion markers (Opa1 and Mfn2) and increased the levels of fission markers Drp1 and Fis1 at the same time point. The percentage of motile mitochondria in neurites also decreased at 72 h, while average speed and total run length per mobile mitochondrion remained unaffected, resulting in an accumulation of stationary mitochondria which may be important, for example, to support neurite extension. Collectively, these findings suggest that while ADB-FUBINACA promotes mitochondrial accumulation in neurites, potentially supporting the energy demands of developing neurites and influencing neurite outgrowth, in the long-term, the fragmentation of the mitochondrial network in the soma may compromise the maintenance of neurites, in terms of energy requirements.

The online version contains supplementary material available at 10.1007/s12035-026-05699-x.

## Linked entities

- **Genes:** OPA1 (OPA1 mitochondrial dynamin like GTPase) [NCBI Gene 4976], MFN2 (mitofusin 2) [NCBI Gene 9927], CRMP1 (collapsin response mediator protein 1) [NCBI Gene 1400], FIS1 (fission, mitochondrial 1) [NCBI Gene 51024]
- **Chemicals:** ADB-FUBINACA (PubChem CID 58124399)

## Full-text entities

- **Genes:** Tm2d1 (TM2 domain containing 1) [NCBI Gene 94043] {aka 2310026L18Rik, Bbp}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Camkk2 (calcium/calmodulin-dependent protein kinase kinase 2, beta) [NCBI Gene 207565] {aka 6330570N16Rik, mKIAA0787}, Mfn1 (mitofusin 1) [NCBI Gene 67414] {aka 2310002F04Rik, 6330416C07Rik, D3Ertd265e, HR2, mKIAA4032}, Cnr2 (cannabinoid receptor 2) [NCBI Gene 12802] {aka CB-2, CB2, CB2-R}, Rhot1 (ras homolog family member T1) [NCBI Gene 59040] {aka 2210403N23Rik, Arht1, C430039G08Rik, Miro1}, Mief1 (mitochondrial elongation factor 1) [NCBI Gene 239555] {aka A230016E22, Smcr7l}, Mfn2 (mitofusin 2) [NCBI Gene 170731] {aka D630023P19Rik, Fzo}, Fis1 (fission, mitochondrial 1) [NCBI Gene 66437] {aka 2010003O14Rik, Ttc11}, Crmp1 (collapsin response mediator protein 1) [NCBI Gene 12933] {aka CRMP-1, DRP-1, Dpysl1, ULIP-3, Ulip3}, Dnm1l (dynamin 1-like) [NCBI Gene 74006] {aka 6330417M19Rik, Dlp1, Dnmlp1, Drp1, python}, Mapt (microtubule-associated protein tau) [NCBI Gene 17762] {aka Mtapt, PHF-tau, Tau}, Opa1 (OPA1, mitochondrial dynamin like GTPase) [NCBI Gene 74143] {aka 1200011N24Rik, lilr3, mKIAA0567}, Aap (active avoidance performance) [NCBI Gene 107417], Cnr1 (cannabinoid receptor 1) [NCBI Gene 12801] {aka CB-R, CB1, CB1A, CB1B, CB1R}
- **Diseases:** brain developmental abnormalities (MESH:D001927), mitochondrial fragmentation (MESH:D012892), embryonal carcinoma (MESH:D018236), glioma (MESH:D005910), neuroblastoma (MESH:D009447), neurotoxic (MESH:D020258), seizures (MESH:D012640), tumour (MESH:D009369), Neuronal Soma (MESH:D009410)
- **Chemicals:** EDTA (MESH:D004492), streptomycin (MESH:D013307), DMSO (MESH:D004121), sodium azide (MESH:D019810), penicillin (MESH:D010406), Tween 20 (MESH:D011136), sucrose (MESH:D013395), PVDF (MESH:C024865), ATP (MESH:D000255), glycerol (MESH:D005990), CCCP (MESH:D002258), polyacrylamide (MESH:C016679), forskolin (MESH:D005576), AMB (MESH:D000666), DTT (MESH:D004229), ADB-FUBINACA (MESH:C000613078), CO2 (MESH:D002245), retinoic acid (MESH:D014212), KCl (MESH:D011189), ACEA (MESH:C119325), HU-210 (MESH:C062018), HEPES (MESH:D006531), THJ-2201 (MESH:C000628091), SDS (MESH:D012967), calcium (MESH:D002118), bromophenol blue (MESH:D001978), magnesium (MESH:D008274), Cannabinoid (MESH:D002186), MgCl2 (MESH:D015636), ADB (-), Delta9-THC (MESH:D013759), PMSF (MESH:D010664), endocannabinoid (MESH:D063388)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** BeWo — Homo sapiens (Human), Gestational choriocarcinoma, Cancer cell line (CVCL_0044), HTR8/Svneo — Homo sapiens (Human), Transformed cell line (CVCL_7162), NG108-15 — Mus musculus (Mouse), Hybrid cell line (CVCL_0464)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12823749/full.md

---
Source: https://tomesphere.com/paper/PMC12823749